194 related articles for article (PubMed ID: 38613897)
1. An emerging role of N-glycosylation in cancer chemoresistance.
Sun Y; Wu T; Gu J
Carbohydr Res; 2024 May; 539():109107. PubMed ID: 38613897
[TBL] [Abstract][Full Text] [Related]
2. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
[TBL] [Abstract][Full Text] [Related]
4. Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.
Sharma A
Nanomedicine (Lond); 2017 Sep; 12(17):2137-2148. PubMed ID: 28805111
[TBL] [Abstract][Full Text] [Related]
5. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.
Nedeljković M; Damjanović A
Cells; 2019 Aug; 8(9):. PubMed ID: 31443516
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance to chemotherapy in non-small cell lung cancer.
Min HY; Lee HY
Arch Pharm Res; 2021 Feb; 44(2):146-164. PubMed ID: 33608812
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation.
Ferreira JA; Peixoto A; Neves M; Gaiteiro C; Reis CA; Assaraf YG; Santos LL
Drug Resist Updat; 2016 Jan; 24():34-54. PubMed ID: 26830314
[TBL] [Abstract][Full Text] [Related]
10. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
12. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.
Alimbetov D; Askarova S; Umbayev B; Davis T; Kipling D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882812
[TBL] [Abstract][Full Text] [Related]
14. ABCG2: the key to chemoresistance in cancer stem cells?
An Y; Ongkeko WM
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
[TBL] [Abstract][Full Text] [Related]
15. Physiological modulation approaches to improve cancer chemotherapy : a review.
Kumar R; Kaur M; Silakari O
Anticancer Agents Med Chem; 2014 Jun; 14(5):713-49. PubMed ID: 24117110
[TBL] [Abstract][Full Text] [Related]
16. ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy.
Dlugosz A; Janecka A
Curr Pharm Des; 2016; 22(30):4705-4716. PubMed ID: 26932159
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of NRF2 in ROS-mediated tumor chemoresistance.
Xue D; Zhou X; Qiu J
Biomed Pharmacother; 2020 Nov; 131():110676. PubMed ID: 32858502
[TBL] [Abstract][Full Text] [Related]
18. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
Xue X; Liang XJ
Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
[TBL] [Abstract][Full Text] [Related]
19. Cancer Chemoresistance; Recent Challenges and Future Considerations.
Adil M; Kanwal S; Rasheed S; Iqbal M; Abbas G
Cancer Treat Res; 2023; 185():237-253. PubMed ID: 37306912
[TBL] [Abstract][Full Text] [Related]
20. TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
Santoro R; Carbone C; Piro G; Chiao PJ; Melisi D
Drug Resist Updat; 2017 Nov; 33-35():36-42. PubMed ID: 29145973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
